Search company, investor...

Founded Year

2017

Stage

Incubator/Accelerator | Alive

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

-232 points in the past 30 days

About BloqCube

BloqCube is a software company specializing in decentralized clinical trial management and financial systems. The company offers an integrated Clinical Trial Management & Financial System (CTMFS) platform designed to accelerate Decentralized Clinical Trials (DCT) by providing a secure, transparent, and efficient way to manage trials and handle financial transactions. BloqCube primarily serves the healthcare and pharmaceutical sectors by streamlining clinical trial processes and financial management. It was founded in 2017 and is based in Piscataway, New Jersey.

Headquarters Location

30 Knightsbridge Road Suite 525

Piscataway, New Jersey, 08854,

United States

908-242-6307

Loading...

BloqCube's Product Videos

BloqCube's Products & Differentiators

    Bloqcube

    e Clinical Platform that integrates into one platform 5 key sub systems - eConsent, eTMF, EDC, CTMS, Finance Module(C2TA)

Loading...

Research containing BloqCube

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned BloqCube in 1 CB Insights research brief, most recently on Jul 18, 2022.

Expert Collections containing BloqCube

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BloqCube is included in 1 Expert Collection, including Digital Health.

D

Digital Health

11,060 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Latest BloqCube News

4th Annual ConV2X 2023 Ignition Pitch Competition Winners Announced

Sep 11, 2023

Pioneering Innovations in AI, Telehealth, and Blockchain Technology in Healthcare Stamford, CT, USA – WEBWIRE – Monday, September 11, 2023 ConV2X 2023 Ignition Pitch Winners The 4th Annual ConV2X 2023 Ignition Pitch Competition, dedicated to advancing the frontiers of telehealth, AI, platform approaches and blockchain technology in healthcare, reached its thrilling conclusion as the judges unveiled the exceptional winners. These pioneering minds are poised to reshape the future of healthcare in areas such as genomics, bio NFTs, decentralized research, AI IQ, and personalized care pathways. First Prize Winners Shine Bright in the following categoriesFirst Prize Winners Shine Bright in the following categories Blockchain Technology in Healthcare: Bloqcube Inc: Clinical Trial Management & Financial System (CTMFS) platform for the acceleration of Decentralized Clinical Trials AI and Digital Health: Veta Health (Prosper): Empowering patients with personalized telehealth solutions The ConV2X 2023 Pitch Competition showcased the brightest minds in healthcare technology. These visionary innovators are poised to revolutionize the healthcare landscape, and their achievements will undoubtedly leave a lasting impact on the industry. Companies that competed for the top accolades alongside the winners included: Quantm AI: Innovating the future of healthcare safety NVFT Bio Oracles (Nvelope LLC): Pioneering bioinformatics solutions for enhanced patient care MyGenoVerse ( Genobank.io ): Unlocking the power of genetic data for personalized healthcare PRIMS (PragmaClin Research Inc): Advancing clinical research with cutting-edge technology Aristotle, BioMe (Theriome Inc.): Shaping the future of healthcare with data-driven insights Competitors all agreed with Dr. Seth Dobrin, CEO, Quantm AI stating: “Wow! What a great group of technologies and use cases. I am humbled by you all, what you have built, and where you are going. It was an honor to be part of this group.” A distinguished Judging Panel, comprised of luminaries from the health, technology, and innovation fund sectors ensured a rigorous evaluation process. The panel included: Nisa Amolis, Managing Partner, A100x Ventures Dr. Fernando De La Peña Llaca, CEO, Aexa Ruby Gadelrab Tudor, CEO, MDsrupt Shwen Gwee, Former VP and Head of Global Digital Strategy, Bristol Myers Squibb Sweta Sneha, PhD, Executive Director of Healthcare Management Informatics. Professor of Information Systems, Coles College of Business, Kennesaw University William Taranto, President, Merck Global Health Innovation Fund Nick Tietz, Founder & CEO, ILT Academy Dr. Shayan Vyas, Executive Physician/Medical Lead, Teladoc, Health Systems “Thank you for organizing the ConV2X 2023 Ignition Pitch event. It is so important that healthcare use cases of blockchain and AI get recognition for their traction, which have been largely ignored by media,” stated Nisa Amoils, Esq., Managing Partner, A100X First prize winners have earned accolades, and remarkable prizes valued at $13,000 each, securing an array of prestigious opportunities that will elevate their ventures to unprecedented heights. The illustrious prizes include a seat on the October 2023 Scholarly Cohort at ILT Entrepreneur Academy , dual all access passes to ConV2X 2023 Hybrid CME events, September 21 & 22, 10 hours of Category 1 CME, complimentary exhibit booth and Speaker Spotlight at ConV2X 2024, multimedia journal amplification, and will judge the 2024 Ignition Pitch Competition. Runner-ups can also embrace success with a waived journal article APC for accepted manuscript submission. For further information and inquiries regarding ConV2X 2024, please contact t.cenaj@partnersindigitalhealthh.com About ConV2X: ConV2X is short for ConVerge-2-Xcelerate – the 7th Annual ConV2X 2023 what’s hot today and what’s coming tomorrow. It’s “One of the leading conferences of innovators at the frontier of blockchain and health and telehealth.” ConV2X is a fresh change of pace from big events – and it pays off in dividends, with many participants finding partners and leads. Curated and easy to navigate, you sit side by side with top global pioneers and leading authorities that care about shaping the future of the healthcare marketplace. The program is evidence based – vetted, and curated to reflect and shape the field bringing NEW researchers and pioneers to a worldwide audience, focusing on how to best harness technology for growth & opportunities across business strategy, career path, and generate a competitive edge for professional ambitions. The curated and collegiate event brings intelligent discussions to the forefront of care bridging research innovation with real world impact and implementations. Registration at ConV2X AI & Tech in Telehealth and Medicine Hybrid CME Program, Sept 22 https://telehealth.conv2xsymposium.com/registration/ ( Press Release Image: https://photos.webwire.com/prmedia/54628/310642/310642-1.jpg )

BloqCube Frequently Asked Questions (FAQ)

  • When was BloqCube founded?

    BloqCube was founded in 2017.

  • Where is BloqCube's headquarters?

    BloqCube's headquarters is located at 30 Knightsbridge Road, Piscataway.

  • What is BloqCube's latest funding round?

    BloqCube's latest funding round is Incubator/Accelerator.

  • Who are the investors of BloqCube?

    Investors of BloqCube include Plug and Play.

  • Who are BloqCube's competitors?

    Competitors of BloqCube include Clinical Research IO and 6 more.

  • What products does BloqCube offer?

    BloqCube's products include Bloqcube and 3 more.

  • Who are BloqCube's customers?

    Customers of BloqCube include Indira Gandhi Medical Research center, india and Grace Cancer Foundation.

Loading...

Compare BloqCube to Competitors

Castor Logo
Castor

Castor is a medical research data platform. It provides decentralized clinical trial solutions to control clinical trial design. It analyzes, manages, and organizes medical data collected from multiple electronic records. The company was founded in 2012 and is based in New York, New York.

Medable Logo
Medable

Medable specializes in providing digital clinical trial software solutions within the healthcare and pharmaceutical sectors. The company offers a comprehensive platform that facilitates the management of clinical trials, including tools for remote data collection, electronic consent (eConsent), patient-reported outcomes (ePRO), and clinical outcome assessments (eCOA), all designed to streamline the trial process and enhance data quality. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.

THREAD Logo
THREAD

THREAD is a company that focuses on providing a decentralized clinical trial platform in the healthcare and life sciences industry. The company offers a platform and supporting services that enable biopharma, CROs, and life science organizations to remotely capture data from participants and sites during, in-between, and in lieu of in-clinic visits. The platform includes features such as electronic consent (eConsent), electronic clinical outcome assessment (eCOA), sensors, reminders, and telehealth virtual visits. It was founded in 2005 and is based in Tustin, California.

JNPMEDI Logo
JNPMEDI

JNPMEDI is an eClinical solutions provider focused on integrating digital technologies into clinical research and trial operations. The company offers a platform for collecting, monitoring, and analyzing medical data, utilizing technologies such as blockchain and cloud to ensure data integrity and operational efficiency. JNPMEDI primarily serves the healthcare industry, specifically sectors involved in clinical trials and research. It was founded in 2020 and is based in Incheon, South Korea.

ObvioHealth Logo
ObvioHealth

ObvioHealth is a company focused on providing digital health solutions, specifically in the realm of decentralized clinical trials. The company offers a suite of services including digital trial design, remote patient monitoring, virtual site services, and integration of sensors and wearable devices. It's platform, ObvioGo, and accompanying services such as electronic patient-reported outcomes (ePRO), electronic consent (eConsent), and clinical outcome assessments (eCOA) streamline the clinical trial process for sponsors and participants. It was founded in 2017 and is based in New York, New York.

Evidation Logo
Evidation

Evidation focuses on harnessing real-world health data to measure and improve health outcomes. The company offers a digital health measurement and engagement platform that utilizes data science and machine learning to provide health guidance, treatments, and tools. Evidation primarily serves life sciences companies, government bodies, and academic institutions. It was founded in 2012 and is based in San Mateo, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.